Li F; Mei H; Gao Y, et al., Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. Biomaterials 2017, 145, 56-71.
Wu Q; Tong L; Zou Z, et al., Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals for enhancing the targeted therapy effect of HER2-positive breast cancer. Materials & Design 2022, 110818.
Shen W; Ge S; Liu X, et al., Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv 2022, 29 (1), 31-42.
Li T Y; Du Y; Wang M C, et al., Cytotoxic Steroidal Saponins Containing a Rare Fructosyl from the Rhizomes of Paris polyphylla var. latifolia. Int J Mol Sci 2023, 24 (8).
Huang M S; Liu J Y; Xia X B, et al., Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway. Front Oncol 2019, 9, 508.
Zhu F; Xu L; Li X, et al., Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC. Eur J Pharm Sci 2021, 167, 106004.
Zheng T; Chou J; Zhang F, et al., CXCR4 3'UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity. Eur J Cell Biol 2015, 94 (10), 458-69.
Zhang C; Liu Y; Yang F, et al., MicroRNA-194-5p/Heparin-binding EGF-like growth factor signaling mediates dexamethasone-induced activation of pseudorabies virus in rat pheochromocytoma cells. Vet Microbiol 2024, 290, 109974.
Pan Z; Wang K; Chen Q, et al., SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells. J Cancer 2020, 11 (2), 334-344.
